Joseph F. Murphy

Array ( [id] => 788074 [patent_doc_number] => 06987006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-17 [patent_title] => 'Erythropoietin and albumin fusion protein, nucleic acids, and methods thereof' [patent_app_type] => utility [patent_app_number] => 10/702636 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 12604 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/987/06987006.pdf [firstpage_image] =>[orig_patent_app_number] => 10702636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 785330 [patent_doc_number] => 06989365 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-24 [patent_title] => 'Methods of treatment with erythropoietin and albumin fusion protein' [patent_app_type] => utility [patent_app_number] => 10/702536 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 12616 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/989/06989365.pdf [firstpage_image] =>[orig_patent_app_number] => 10702536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410935 [patent_doc_number] => 20040106550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Remedies for arthritis deformans and remedies for rheumatoid arthritis' [patent_app_type] => new [patent_app_number] => 10/469393 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8365 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106550.pdf [firstpage_image] =>[orig_patent_app_number] => 10469393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7317666 [patent_doc_number] => 20040224386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Protein tyrosine kinases' [patent_app_type] => new [patent_app_number] => 10/646760 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 30517 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224386.pdf [firstpage_image] =>[orig_patent_app_number] => 10646760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7406401 [patent_doc_number] => 20040024186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Method of purifying protein from inclusion bodies' [patent_app_type] => new [patent_app_number] => 10/630932 [patent_app_country] => US [patent_app_date] => 2003-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 19018 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20040024186.pdf [firstpage_image] =>[orig_patent_app_number] => 10630932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847694 [patent_doc_number] => 20030166861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Human blue-light photoreceptor hCRY2' [patent_app_type] => new [patent_app_number] => 10/413536 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16687 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166861.pdf [firstpage_image] =>[orig_patent_app_number] => 10413536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846983 [patent_doc_number] => 20030166150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Asthma associated factors as targets for treating atopic allergies including asthma and related disorders' [patent_app_type] => new [patent_app_number] => 10/348190 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16661 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166150.pdf [firstpage_image] =>[orig_patent_app_number] => 10348190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730143 [patent_doc_number] => 20030186333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Down syndrome critical region 1-like protein' [patent_app_type] => new [patent_app_number] => 10/290438 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23734 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186333.pdf [firstpage_image] =>[orig_patent_app_number] => 10290438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7619945 [patent_doc_number] => 06943238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-13 [patent_title] => 'Antibodies to cyclin E2 protein' [patent_app_type] => utility [patent_app_number] => 10/265062 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 17605 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943238.pdf [firstpage_image] =>[orig_patent_app_number] => 10265062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838832 [patent_doc_number] => 20030036172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Fusion polypeptides of human serum albumin and a therapeutically active polypeptide' [patent_app_type] => new [patent_app_number] => 10/237871 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 12587 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036172.pdf [firstpage_image] =>[orig_patent_app_number] => 10237871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 710300 [patent_doc_number] => 07056701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Hormone and albumin fusion protein' [patent_app_type] => utility [patent_app_number] => 10/237624 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 12560 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056701.pdf [firstpage_image] =>[orig_patent_app_number] => 10237624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 938493 [patent_doc_number] => 06972322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-06 [patent_title] => 'Interferon and albumin fusion protein' [patent_app_type] => utility [patent_app_number] => 10/237866 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 12591 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972322.pdf [firstpage_image] =>[orig_patent_app_number] => 10237866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728029 [patent_doc_number] => 07041478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'G-CSF and albumin fusion protein' [patent_app_type] => utility [patent_app_number] => 10/237667 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 12556 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041478.pdf [firstpage_image] =>[orig_patent_app_number] => 10237667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6735508 [patent_doc_number] => 20030013143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Methods for identifying vasoprotective agents' [patent_app_type] => new [patent_app_number] => 10/238664 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10439 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013143.pdf [firstpage_image] =>[orig_patent_app_number] => 10238664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838830 [patent_doc_number] => 20030036170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Fusion polypeptides of human serum albumin and a therapeutically active polypeptide' [patent_app_type] => new [patent_app_number] => 10/237708 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 12579 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036170.pdf [firstpage_image] =>[orig_patent_app_number] => 10237708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083808 [patent_doc_number] => 20050049188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'MOLECULAR CLONING OF A 7TM RECEPTOR (AXOR34) AND SCREENING METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 10/215619 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12570 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049188.pdf [firstpage_image] =>[orig_patent_app_number] => 10215619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869951 [patent_doc_number] => 20030082640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'LDL receptor signaling pathways' [patent_app_type] => new [patent_app_number] => 10/211962 [patent_app_country] => US [patent_app_date] => 2002-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6899 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082640.pdf [firstpage_image] =>[orig_patent_app_number] => 10211962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692620 [patent_doc_number] => 20030040052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Novel G-protein coupled receptors' [patent_app_type] => new [patent_app_number] => 10/167192 [patent_app_country] => US [patent_app_date] => 2002-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 39980 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040052.pdf [firstpage_image] =>[orig_patent_app_number] => 10167192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6656525 [patent_doc_number] => 20030077731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Human Elk, a voltage-gated potassium channel subunit' [patent_app_type] => new [patent_app_number] => 10/160224 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23323 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077731.pdf [firstpage_image] =>[orig_patent_app_number] => 10160224 [rel_patent_id] =>[rel_patent_doc_number] =>)